Prevagen demonstrated the ability to improve aspects of cognitive function in subgroups of participants who were cognitively normal or mildly impaired.
The group of participants taking Prevagen improved according to computer-based testing. The adults were over 40 years old and took one capsule daily for 90 days
Apoaequorin, the unique ingredient in Prevagen, has undergone extensive Safety Testing. Tests for allergenicity and toxicity have been conducted.